Physician profile
Matthew John Meier
NPI 1891914198
$982.71
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $169 · 2021: $14.53 · 2022: $14.40 · 2023: $94.99 · 2024: $99.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $194.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $211.20 | 2019-2024 | Tremfya |
| Abbvie INC. | $182.13 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $95.30 | 2019-2020 | |
| Lilly USA, LLC | $87.77 | 2019-2020 | |
| Pfizer INC. | $58.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $57.52 | 2019 | |
| Amgen INC. | $47.89 | 2019-2020 | |
| Ucb, INC. | $42.85 | 2019 | |
| Vyne Pharmaceuticals INC. | $29.64 | 2020 | |
| Leo Pharma INC. | $28.93 | 2021-2022 | |
| Galderma Laboratories, L.P. | $27.97 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $25.27 | 2019 | |
| Mayne Pharma Commercial LLC | $22.66 | 2020 | |
| Celgene Corporation | $22.11 | 2019 | |
| Almirall LLC | $16.92 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $15.07 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Meier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.